Business
Press Release Mar 13 2026
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg".
About this update from Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg". View Attachment
View stock analysis, news, and events for Zydus Lifesciences Limited